← Leaderboards
Christian Sell
Lankenau Institute For Medical Research
$5,121,309
Attributed
$5,518,557
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $901K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,518,557 · 7
By mechanism
R01$3,869,527 · 2
R25$794,496 · 1
R21$424,875 · 1
R56$310,489 · 1
R03$75,000 · 1
R13$44,170 · 1
Top collaborators
- Rose Ann Dimaria-Ghalili2 shared
Others in their field
Top investigators on “Longevity”
- Chanza Baytop · Westat, Inc.$146,068,012
- Lee Marshall Nadler · Dana-Farber Cancer Inst$90,363,087
- Michael A Province · Washington University$72,611,872
- Judith Kasper · Johns Hopkins University$69,575,962
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$64,213,010
- Thomas T Perls · Beth Israel Deaconess Medical Center$61,138,423
Research focus
LongevityTissuesCellsSignal TransductionMediatingAge RelatedPathway InteractionsAgingMetabolicAlzheimer&AposResponseRegulationPlayElderlyPreventMemberProgramsGrantFrap1 GeneMouse ModelAdult Stem CellFunctional DisorderMtor InhibitionMtor Inhibitor
Grant awards (19)
Novel longevity enhancing pathways regulated by mTOR$428,973
R01 · FY2025 · AG · contact PI
Drexel DREAM (health Disparities, Research, Experiential Learning, Aging Science, and Mentorship) Scholars Program$389,496
R25 · FY2025 · AG
Novel longevity enhancing pathways regulated by mTOR$437,727
R01 · FY2024 · AG · contact PI
Drexel DREAM (Diversity, Research, Experiential Learning, Aging Science, and Mentorship) Scholars Program$405,000
R25 · FY2024 · AG
Novel longevity enhancing pathways regulated by mTOR$58,263
R01 · FY2024 · AG · contact PI
Novel longevity enhancing pathways regulated by mTOR$413,912
R01 · FY2023 · AG · contact PI
Novel longevity enhancing pathways regulated by mTOR$385,125
R01 · FY2023 · AG · contact PI
Novel longevity enhancing pathways regulated by mTOR$396,259
R01 · FY2022 · AG · contact PI
Novel longevity enhancing pathways regulated by mTOR$310,489
R56 · FY2021 · AG · contact PI
47th Annual Meeting of the American Aging Association$44,170
R13 · FY2018 · AG · contact PI
Novel models for longevity research$231,750
R21 · FY2012 · AG · contact PI
Novel models for longevity research$193,125
R21 · FY2011 · AG · contact PI
Role of IGF-1 in Modulation of Longevity$238,006
R01 · FY2009 · AG · contact PI
Role of IGF-1 in Modulation of Longevity$419,901
R01 · FY2008 · AG · contact PI
Role of IGF-1 in Modulation of Longevity$332,623
R01 · FY2007 · AG · contact PI
Role of IGF-1 in Modulation of Longevity$116,370
R01 · FY2007 · AG · contact PI
Role of IGF-1 in Modulation of Longevity$357,932
R01 · FY2006 · AG · contact PI
Role of IGF-1 in Modulation of Longevity$284,436
R01 · FY2005 · AG
IGF-1 and Longevity in Mammals$75,000
R03 · FY2002 · AG